| Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins F Baruffaldi, AH Kelcher, M Laudenbach, V Gradinati, A Limkar, ... Molecular pharmaceutics 15 (11), 4947-4962, 2018 | 49 | 2018 |
| Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity C Robinson, V Gradinati, F Hamid, C Baehr, B Crouse, S Averick, ... Journal of medicinal chemistry 63 (23), 14647-14667, 2020 | 34 | 2020 |
| Preclinical efficacy and selectivity of vaccines targeting fentanyl, alfentanil, sufentanil, and acetylfentanyl in rats C Baehr, C Robinson, A Kassick, R Jahan, V Gradinati, SE Averick, ... ACS omega 7 (19), 16584-16592, 2022 | 18 | 2022 |
| Efficacy and selectivity of monovalent and bivalent vaccination strategies to protect against exposure to carfentanil, fentanyl, and their mixtures in rats B Crouse, MM Wu, V Gradinati, AJ Kassick, D Song, R Jahan, S Averick, ... ACS Pharmacology & Translational Science 5 (5), 331-343, 2022 | 14 | 2022 |
| Polymer-mediated delivery of vaccines to treat opioid use disorders and to reduce opioid-induced toxicity V Gradinati, F Baruffaldi, S Abbaraju, M Laudenbach, R Amin, B Gilger, ... Vaccine 38 (30), 4704-4712, 2020 | 5 | 2020 |
| New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science J Aubé, CW Lindsley, CE Müller, RW Sabnis, C Adam, TL Bray, ... J. Med. Chem 66 (12), 7669-7669, 2023 | 1 | 2023 |
| Selected Toll‐like receptor agonists increase the efficacy of vaccines against fentanyl use disorder and overdose B Crouse, S Miller, C Robinson, V Gradinati, L Hicks, C Buhl, M Whitacre, ... The FASEB Journal 35, 2021 | | 2021 |
| IND‐enabling studies of vaccines to treat heroin and oxycodone use disorders M Raleigh, S King, A Saykao, C Robinson, F Baruffaldi, V Gradinati, ... The FASEB Journal 35, 2021 | | 2021 |
| Functional in vivo characteristics of antibodies generated by an oxycodone vaccine MD Raleigh, SJ King, AT Saykao, F Baruffaldi, V Gradinati, S Winston, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Development of vaccines for treatment of opioid abuse using carrier proteins suitable for pharmaceutical manufacturing AM Huseby Kelcher, V Gradinati, A Limkar, F Baruffaldi, A Lees, ... The Journal of Immunology 200 (1_Supplement), 181.28-181.28, 2018 | | 2018 |
